Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Foundation for Liver Research
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Chronic hepatitis B (HBsAg positive \> 6 months)
HBeAg positive, anti-HBe negative at screening
ALT \> 1.3 x ULN within 60 days prior to screening and during screening
Liver biopsy performed within 2 years prior to screening or during screening
Age \> 18 years
Written informed consent
Adequate contraception for males and females during treatment and follow up; negative pregnancy test (for women of childbearing potential)
Immune suppressive treatment within the previous 6 months
Contra-indications for alpha-interferon therapy like suspected hypersensitivity to interferon or PEG-interferon or any known pre-existing medical condition that could interfere with the patient's participation in and completion of the study.
Pregnancy, lactation
Other significant medical illness that might interfere with this study: significant pulmonary dysfunction in the previous 6 months, malignancy other than skin basocellular carcinoma in previous 5 years, immunodeficiency syndromes (e.g. HIV positivity, auto-immune diseases, organ transplants other than cornea and hair transplant)
Any medical condition requiring, or likely to require chronic systemic administration of steroids, during the course of the study
Substance abuse, such as alcohol (\> 80 g/day), I.V. drugs and inhaled drugs in the past 2 years.
Any other condition which in the opinion of the principal investigator would make the patient unsuitable for enrollment, or could interfere with the patient participating in and completing the study
You may not be if
Antiviral therapy against HBV within the previous 6 months
Treatment with any investigational drug within 30 days of screening
Previous treatment with lamivudine or telbivudine for more than six months
Severe hepatitis activity as documented by ALT\>10 x ULN
History of decompensated cirrhosis (defined as jaundice in the presence of cirrhosis, ascites, bleeding gastric or esophageal varices or encephalopathy)
Pre-existent neutropenia (neutrophils \< 1,500/mm3) or thrombocytopenia (platelets \< 90,000/mm3)
Co-infection with hepatitis C virus or human immunodeficiency virus (HIV)
Other acquired or inherited causes of liver disease (i.e. alcoholic liver disease, obesity induced liver disease, drug related liver disease, auto-immune hepatitis, hemochromatosis, Wilson's disease or alpha-1 antitrypsin deficiency)